Inflammatory bone loss in joint replacements: The mechanisms
June 1, 2010
More than 1 million total joint arthroplasties (TJAs) are performed in the United States each year, and much higher demand is projected. Most TJAs are successful, but aseptic loosening of implants remains a problem that limits long-term success. Aseptic osteolysis, an inflammatory reaction, occurs in up to 10% of patients at 10 years postsurgery.
The use of biologic agents in the geriatric population
April 30, 2010
ABSTRACT: The aging process is difficult, involving multisystem functional decline, and the pharmacokinetics of medications are altered in the older population, resulting in increased risks. Concerns associated with biologic therapy are demonstrated in case reports.
All about osteoporosis: Meeting the treatment challenge
April 29, 2010
 Following the release of revised National Osteoporosis Foundation guidelines and of the World Health Organization’s fracture risk assessment tool, several pharmacological therapies have become available to help improve outcomes in patients with osteoporosis.
Supplement: Focus on Rheumatology
|
Featured Resource Centers
What can an MRI detect about RA that a radiographic analysis cannot? Find the answer, plus news, features, and new podcasts about treatment targets and biologics, comorbidities, future treatments, and health reform at our Rheumatoid Arthritis Resource Center.  Which agents provide the most effective treatment for patients who experience the pain of osteoarthritis? Find the answers, plus news, features, and special resources at our Osteoarthritis Resource Center.
|
